Exchange: NASDAQ·Updated 03:17 PM EDT

SYBX Synlogic Inc

$1.22
$0.0075
(0.62%)
Today
Reported EarningsNov 12
Mkt Cap$14.94M
Vol527.00

About SYBX

Synlogic, Inc. is a biopharmaceutical company which engages in the discovery and development of synthetic biotic medicines. It focuses on phenylketonuria, enteric hyperoxaluria, immuno-oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs. The company was founded by James J. Collins and Timothy K. Lu on December 20, 2007 and is headquartered in Cambridge, MA.
52

Neutral Sentiment

How do you feel about SYBX?

Advertisement|Remove ads.